Cesium carbonate → (R)-N-(6-(methylthio)thiazolo[5,4-b]pyrazin-2-yl)-4H-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octan]-2-amine

HRID 250100Notes

Reaction equation

HRID 250100 reaction equation
Br[C:2]1[N:7]=[C:6]2[S:8][C:9]([N:11]=[C:12](SC)SC)=[N:10][C:5]2=[N:4][CH:3]=1.Cl.Cl.[NH2:19][CH2:20][C@@:21]1([OH:29])[CH:26]2[CH2:27][CH2:28][N:23]([CH2:24][CH2:25]2)[CH2:22]1.C(=O)([O-])[O-].[Cs+].[Cs+].[CH3:36][S-:37].[Na+]>CN(C=O)C.O>[CH3:36][S:37][C:2]1[N:7]=[C:6]2[S:8][C:9]([NH:11][C:12]3[O:29][C@:21]4([CH2:20][N:19]=3)[CH:26]3[CH2:25][CH2:24][N:23]([CH2:28][CH2:27]3)[CH2:22]4)=[N:10][C:5]2=[N:4][CH:3]=1

Participants

7

Conditions

Temperature
100 °C

Procedure

A mixture of dimethyl 6-bromothiazolo[5,4-b]pyrazin-2-ylcarbonimidodithioate from Step A of Example 263 (100 mg, 0.298 mmol), (S)-3-(aminomethyl)quinuclidin-3-ol dihydrochloride (68 mg, 0.298 mmol) and cesium carbonate (100 mg, 0.60 mmol) in DMF (1.5 mL) was placed in a 1 dram vial and heated on a 100° C. oil bath for 1 hour, at which time, sodium thiomethoxide (100 mg, 1.43 mmol) was added and the mixture was heated overnight. The mixture was cooled to ambient temperature and poured into water (20 mL) and the resulting solids were collected by filtration and then purified by silica gel chromatography (2-40% 9:1 methanol:ammonium hydroxide-chloroform). The product fractions were combined and concentrated in vacuo to afford (R)—N-(6-(methylthio)thiazolo[5,4-b]pyrazin-2-yl)-4H-1′-azaspiro[oxazole-5,3′-bicyclo[2.2.2]octan]-2-amine (52 mg, 46% yield). 1H NMR (500 MHz, CDCl3) δ ppm 9.39 (br. s., 1 H) 8.31 (s, 1 H) 4.03 (d, J=9.77 Hz, 1 H) 3.70 (d, J=9.77 Hz, 1 H) 3.41 (dd, J=14.95, 1.83 Hz, 1 H) 2.73-3.10 (m, 5 H) 2.63 (s, 3 H) 2.10-2.25 (m, 2 H) 1.47-1.86 (m, 3 H). MS (LC/MS) R.T.=1.04; [M+H]+=363.04.

Workup

  1. temperaturethe mixture was heated overnight
  2. temperatureThe mixture was cooled to ambient temperature
  3. filtrationthe resulting solids were collected by filtration
  4. custompurified by silica gel chromatography (2-40% 9:1 methanol:ammonium hydroxide-chloroform)
  5. concentrationconcentrated in vacuo

Sources & evidence

ORD record
ord-40cccc790b904f0faa9221fa4dbf93a1
Source dataset
uspto-grants-2011_01
Patent number
US07863291B2

Reaction notes

Loading…